Real-world Demographics, Clinical Characteristics, Treatment Patterns and Clinical Outcomes for US Patients with Limited-Stage SCLC (LS-SCLC)

被引：0

作者：

Chiang, Anne C. ^{[1
]}

Salomonsen, Rachel ^{[2
]}

Wang, Alice ^{[2
]}

Holland, Rachel ^{[3
]}

Cai, Ling ^{[2
]}

Xiao, Yang ^{[2
]}

Sadow, Sam ^{[2
]}

Davey, Kieran ^{[3
]}

Iyengar, Puneeth ^{[4
]}

机构：

[1] Yale Univ, Sch Med, New Haven, CT USA

[2] AstraZeneca, Gaithersburg, MD USA

[3] AstraZeneca, Cambridge, England

[4] UT Southwestern Med Ctr, Dallas, TX USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PP01.90

引用

页码：E40 / E41

页数：2

共 50 条

[1] Demographics, clinical characteristics, treatment (tx) patterns and clinical outcomes for patients ( pts) with limited-stage SCLC (LS-SCLC)
Chiang, A. C.
Salomonsen, R. J-B.
Wang, A.
Holland, R.
Cai, L.
Xiao, Y.
Sadow, S.
Davey, K.
Iyengar, P.
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S132 - S133
[2] Real-World Survival Outcomes of Patients with Limited Stage Small Cell Lung Cancer (LS-SCLC) by Choice of Platinum Chemotherapy
Kerrigan, K.
Sinnott, J.
Haaland, B.
Puri, S.
Akerley, W.
Patel, S.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1186 - S1187
[3] Cisplatin versus carboplatin for the treatment of limited-stage small cell lung cancer (LS-SCLC).
Azar, Ibrahim
Austin, Adam
Kim, Seongho
Jang, Hyejeong
Surapaneni, Malini
Kurtz, Daniel
Yazdanpanah, Omid
Chopra, Amit
Mehdi, Syed
Mamdani, Hirva
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[4] Patterns of practice in limited-stage small cell lung cancer (LS-SCLC) among radiation oncologists
Movsas, Benjamin
Sun, Alexander
Komaki, Ritsuko
Bonner, James
Choy, Hak
Gaspar, Laurie
Sandler, Howard M.
Kong, Feng-Ming
CHEST, 2007, 132 (04) : 589S - 589S
[5] Adaptive radiation therapy (ART) for patients with limited-stage small cell lung cancer (LS-SCLC): A dosimetric evaluation
Sager, Omer
Dincoglan, Ferrat
Demiral, Selcuk
Uysal, Bora
Gamsiz, Hakan
Ozcan, Fatih
Colak, Onurhan
Elcim, Yelda
Gundem, Esin
Dirican, Bahar
Beyzadeoglu, Murat
INDIAN JOURNAL OF CANCER, 2023, 60 (01) : 140 - 147
[6] ADRIATIC: Durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC).
Spigel, David R.
Cheng, Ying
Cho, Byoung Chul
Laktionov, Konstantin K.
Fang, Jian
Chen, Yuanbin
Zenke, Yoshitaka
Lee, Ki Hyeong
Wang, Qiming
Navarro, Alejandro
Bernabe Caro, Reyes
Buchmeier, Eva Lotte
Chang, John W. C.
Okamoto, Isamu
Goksu, Sema Sezgin
Badzio, Andrzej
Gill, Bethany
Gowda, Hema
Jiang, Haiyi
Senan, Suresh
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (17_SUPPL)
[7] Improving outcomes for limited stage small cell lung cancer (LS-SCLC) patients in Scotland with concomitant chemoradiation
Law, A
Kerr, G
Mackean, M
Erridge, S
Little, F
Ironside, J
Price, A
LUNG CANCER, 2005, 49 : S324 - S324
[8] Durvalumab (D) as consolidation therapy in limited-stage SCLC (LS-SCLC): Outcomes by prior concurrent chemoradiotherapy (cCRT) regimen and prophylactic cranial irradiation (PCI) use in the ADRIATIC trial
Senan, S.
Spigel, D. R.
Cho, B. C.
Laktionov, K.
Zenke, Y.
Lee, K. H.
Wang, Q.
Mendivil, A. F. Navarro
Buchmeier, E. L.
Goksu, S. Sezgin
Badzio, A.
Shi, A.
Daniel, D. B.
Zemanova, M.
Iyengar, P.
Paz-Ares, L. G.
Szadkowski, L.
Chugh, P.
Lai, W. C. V.
Cheng, Y.
ANNALS OF ONCOLOGY, 2024, 35 : 1267 - 1268
[9] Phase I study with pemetrexed, cisplatin and concurrent radiotherapy in limited-stage small cell lung cancer (LS-SCLC)
Surmont, V.
Nackaerts, K.
Senan, S.
Kraaij, C. J.
Chouaki, N.
van Klaveren, R. J.
Vansteenkiste, J.
Smit, E. F.
EJC SUPPLEMENTS, 2009, 7 (02): : 541 - 541
[10] Real-World Analysis of Clinical Characteristics and Survival Outcomes in Patients With Extensive-Stage SCLC Treated With First-Line Chemoimmunotherapy
Wang, Yang
Mathai, Jared
Alamgeer, Muhammad
Parakh, Sagun
Paul, Eldho
Mitchell, Paul
Arulananda, Surein
JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (08):

← 1 2 3 4 5 →